Ionis Pharmaceuticals | تكلفة المبيعات



Cost Of Sales تغيير تاريخ
Adcock Ingram Holdings ZAR 3.18B 115.21M 2024-12
Agios Pharmaceuticals USD 1.7M 617K 2025-06
Alnylam Pharmaceuticals USD 142.95M 71.91M 2025-06
Astellas Pharma JPY 94.83B 17.97B 2025-06
BioMarin Pharmaceutical USD 154.94M 3.38M 2025-06
Celltrion KRW 399.04B 120.81B 2025-03
Cspc Pharmaceutical CNY 2.31B 299.94M 2025-03
Divis Laboratories Ltd 10.68B 870M 2025-06
Exelixis USD 19.47M 298K 2025-07
Halozyme Therapeutics USD 64.12M 15.72M 2025-06
Ionis Pharmaceuticals USD 4.15M 3.15M 2025-06
Kangmei Pharma CNY 1.03B 35.75M 2025-06
Knight Therapeutics CAD 47.25M 990K 2024-09
Laboratorios Farma EUR 54.41M 97.64M 2025-06
Malin Corporation EUR 15.4M 0 2020-12
Medical Developments International AUD 5.27M 2.92M 2024-12
Moderna USD 119M 29M 2025-06
Neurocrine Biosciences USD 11.3M 2.1M 2025-06
Novartis USD 3.32B 95M 2025-06
OPKO Health USD 137.75M 38.75M 2025-06
Organigram Holdings CAD 44.65M 2.96M 2025-06
Pfizer USD 4.99B 2.4B 2025-06
Pharma Mar EUR 2.78M 620K 2025-06
PTC Therapeutics USD 15.48M 2.62M 2025-06
Qiagen NV USD 199.25M 24.48M 2025-06
Regeneron Pharmaceuticals USD 530.2M 264.7M 2025-06
Roche Holding CHF 4.13B 393.5M 2024-12
Sarepta Therapeutics USD 153.22M 15.66M 2025-06
Sartorius EUR 468.1M 16.1M 2025-06
Sino Biopharmaceutical CNY 2.49B 353.34M 2024-12
Tilray USD 149.73M 9.39M 2024-11
Ultragenyx Pharmaceutical USD 23M 5.66M 2025-06
Vertex Pharmaceuticals USD 407.5M 44.5M 2025-06
Zz Pientze Pharmaceu 1.94B 214.76M 2025-06


Ionis Pharmaceuticals تكلفة المبيعات - القيم الحالية، والبيانات التاريخية، والتنبؤات والإحصاءات والرسوم البيانية والتقويم الاقتصادي - Sep 2025.